SAN CLEMENTE, Calif., Feb. 22, 2013 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical devices used in infusion therapy, oncology and critical care applications, today announced that Company management will be presenting at the Raymond James 34th Annual Institutional Investors Conference to be held on March 3-6, 2013, at the JW Marriott Grande Lakes Hotel in Orlando, Florida.
ICU Medical's presentation will take place on Wednesday, March 6, at 7:30 AM Eastern Time.
The presentation will be webcast live and can be accessed by going to the Company's website at http://www.icumed.com, clicking on the Investors tab and clicking on the Event Calendar tab. The webcast will also be available by replay.
A copy of the slides to be presented may be found by going to the Company's website at http://www.icumed.com, clicking on the Investors tab, clicking on Presentations and clicking on the March 2013 Investor Presentation.
About ICU Medical, Inc.
ICU Medical, Inc. develops, manufactures and sells innovative medical technologies used in infusion therapy, oncology, and critical care applications. ICU Medical's products improve patient outcomes by helping prevent bloodstream infections and protecting healthcare workers from exposure to infectious diseases or hazardous drugs. The company's complete product line includes custom I.V. systems, closed delivery systems for hazardous drugs, needlefree I.V. connectors, catheters and cardiac monitoring systems. ICU Medical is headquartered in San Clemente, California. For more information, visit the Company's website at www.icumed.com.
CONTACT: ICU Medical, Inc. Scott E. Lamb, Chief Financial Officer (949) 366-2183 ICR, LLC John F. Mills, Senior Managing Director (310) 954-1105Source:ICU Medical, Inc.